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The diagnosis of a testicular sclerosing Sertoli cell tumor is rare. Approximately 17 cases have been
previously described in the literature worldwide. We present a case and review the evaluation and
surgical management of a sclerosing Sertoli cell tumor presenting in a 26 year-old African-American
adult, in association with testicular microlithiasis and oligospermia. Imaging techniques and the path-
ological assessment will be reviewed.
 2015 The Author. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/3.0/).Introduction
A high level of suspicion is required when any young adult male
presents to the ofﬁcewith a history of “testicular pain” or “testicular
mass.” The initial evaluation would include a thorough history and
physical exam, pertinent laboratory testing and/or imaging studies.
Surgical exploration may be indicated. Germ cell tumors comprise
90e95% of all primary testicular tumors, and, as such, non-germ cell
tumors are less common. A case of a 26 year-old African-American
male patient diagnosed with a sclerosing Sertoli cell tumor of the
left testis is presented.Case presentation
Areferralwasmade forevaluationof apatientwith “testicularpain”
and abnormal ﬁndings noted on a scrotal ultrasound. A 26 year-old
African-American patient presented with left orchialgia ongoing for
several weeks. He denied any history of trauma, urinary tract in-
fections, at risk sexual behavior, urolithiasis or a history of cryptor-
chidism. He did report some minor urinary frequency. His physical
examwas unremarkable. There was no gynecomastia, lymphadenop-
athy, or palpable testicular masses. A scrotal ultrasound had been
performed, revealing bilateral testicular microlithiasis and a “smallþ1 772 465 2111.
nc. This is an open access article umassor lesionmeasuring6mm” in the superior pole of the left testicle.
No suspicious lesionswere identiﬁed in the right testicle. Serum tumor
markers (lactic acid dehydrogenase 168 U/L, alpha-fetoprotein 6.9 ng/
mL and serum beta human chorionic gonadotropin <2.0 mIU/mL)
were within normal range. His basic metabolic panel was normal. A
chest radiograph showed no evidence of metastasis. A conﬁrmatory
MRI without and with contrast was ordered and revealed a small 6e
7mm,well-circumscribed, lobular lesion of decreased signal intensity
onT2-weighted images located in thesuperior,medial aspectof the left
testicle (Fig.1). No signiﬁcant contrast enhancementwasnoted, andno
obvious tunica penetration was visualized. Incidental images of the
retroperitoneumrevealed no obvious lymphadenopathy. Adifferential
diagnosis includedagermcell testicular tumor (GCTT), a non-germcell
testicular tumor (NGCTT), and ametastatic tumor to the testicle. A pre-
treatment semen analysis revealed oligoasthenospermia.
Management
A lengthy pre-operative discussion was had with the patient,
and a thorough informed consent was obtained. A left scrotal
exploration via an inguinal approach was planned, with consid-
eration of either a partial orchiectomy versus a radical orchiec-
tomy. The patient stressed the concern for possible future fertility.
The patient was explored through a left inguinal incision
under general anesthesia. The testis was mobilized from the
gubernaculum and brought into the surgical ﬁeld. Temporary
hemostasis was achieved using a Penrose drain around thender the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
Figure 1. T2-weighted MRI image of superior pole lesion.
Figure 2. Microscopic pathologic analysis at 400 with hematoxylin and eosin
staining revealing nests and cords with dense collagenous stroma.
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ginea was incised in the anterior midline below the epididymal
head. The superior portion of the seminiferous tubules was bluntly
mobilized, allowing incorporation of the suspected lesion seen on
preoperative imaging with wide surgical margins. The specimen
was immediately taken to pathology, where both surgeon and
pathologist reviewed the slides. A wide margin was obtained
around a small, deﬁnite solid lesion without the appearance of a
germ cell neoplasm. A histological diagnosis of a benign sclerosing
Sertoli cell tumor was determined, pending additional special
staining. A decision was made to preserve the left testicle.
Approximation and closure was performed. The patient recovered
well, and was seen the following week for a post-operative eval-
uation and discussion.
Initial pathology revealed a 5 mm ﬁrm, whitish-tan nodule,
without evidence of mitosis and consistent with a benign sclerosing
Sertoli cell tumor. Surrounding normal seminiferous tubules were
noted. A consultation was sent for additional staining. The tumor
consisted of “nest and cords of cells set in a densely collagenous
stroma” (Fig. 2). Small nuclei and clear cytoplasm was evident.
Immunostains revealed diffuse positivity for vimentin (Fig. 3) and
inhibin and negative staining for PLAP and keratin. According to the
ﬁnal pathology report, this “combination of features is diagnostic of
a sclerosing Sertoli cell tumor.”Figure 3. Microscopic pathologic analysis at 400 with vimentin immunostaining
revealing diffuse positivity.Discussion
We present here a report of a rare non-germ cell testicular tumor.
To our knowledge, approximately 18 cases of a sclerosing Sertoli cell
tumor, including ours, have been described in both the English and
non-English literature. First characterized by Zuckerberg et al,1 10
initial cases were reviewed and designated to be “sclerosing Sertoli
cell tumors.” Their original description in 1991 remains the initial
report of the clinical and pathologic features typical of a sclerosing
Sertoli cell tumor. Mean patient age was 34.6 years and ranged from
18 to 80 years. All tumors presented unilaterally. No excessive hor-
mone production was evident in any patient. Pathologic ﬁndings
were (1) small, well-demarcated tumors (0.4e1.5 cm), (2) yellow-
white or tan coloration and (3) containment within the testicularparenchyma. Histologic ﬁndingswere described as “solid and hollow,
simple and anastomosing tubules, large irregular aggregates, and
thin cords of Sertoli cells in a prominent collagenous background.”
One patient had histologically malignant features, however, he died
5 years after diagnosis from cardiac disease without evidence of
recurrence or metastasis. Other reports describe similar pathologic
and histologic ﬁndings, and the malignant potential for sclerosing
Sertoli cell tumors remains low.2e4
The tumor removed from our patient reveals similar patho-
logic ﬁndings, histologic characteristics and staining patterns.
Bilateral testicular microlithiasis and an abnormal semen anal-
ysis are particularly noted in our patient. In reviewing the
available literature, to our knowledge, we report the ﬁrst patient
diagnosed with a benign sclerosing Sertoli cell tumor presenting
with bilateral testicular microlithiasis and an abnormal semen
analysis. Given the low malignant potential of this lesion and
our patient’s abnormal pre-operative semen analysis, we pro-
pose a testicular-sparing approach for preservation of testicular
function in face of potential future infertility concerns. Others
have also suggested a testicular-sparing approach for small,
incidental testicular lesions.5 If an intra-operative pathological
diagnosis of a benign tumor can be established, then a partial
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diagnosis remains in question, then a radical orchiectomy should
remain the procedure of choice. To date, our patient has not
demonstrated any evidence of disease recurrence at 10 months.
This report should be added to the limited available literature
for sclerosing Sertoli cell tumors.Conﬂict of interest
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